EVOK
insider transactionsEvoke Pharma Inc — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-9.0K
0 buy · 9.0K sell
Net value · 365d
-$95.9K
$0 in · $95.9K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
2
0 buy · 9.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
5.8K sh
Own -100%
-
Other·D
Director
—
5.8K sh
Own -100%
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
5.8K sh
Own -100%
-
Other·D
Chief Executive Officer
—
70.0K sh
Own -100%
-
Other·D
Chief Executive Officer
—
64.8K sh
Own -100%
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
5.8K sh
Own -100%
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
5.8K sh
Own -100%
-
Other·D
Director
—
1.1K sh
Own -100%
-
Other·D
Director
—
1.2K sh
Own -100%
-
Other·D
Director
—
5.8K sh
Own -100%
-
Other·D
Chief Medical Officer
—
11.0K sh
Own -100%
-
Other·D
Chief Medical Officer
—
17.3K sh
Own -100%
-
Other·D
Director
—
8.8K sh
Own -100%
-
Other·D
Director
—
1.3K sh
Own -100%
-
Other·D
Director
—
1.5K sh
Own -100%
-
Other·D
Kowieski Mark KEY
Chief Financial Officer
—
13.0K sh
Own -100%
-
Other·D
Kowieski Mark KEY
Chief Financial Officer
—
17.3K sh
Own -100%
-
Other·J
TenPercentOwner
$4.8M
434.0K sh · $11.00
-
Other·J
TenPercentOwner
$551.2K
117.0K sh · $4.71
-
Other·J
TenPercentOwner
$551.2K
117.0K sh · $4.71
-
Other·J
TenPercentOwner
$1.7M
158.5K sh · $10.99
-
Other·J
TenPercentOwner
$2.8M
250.6K sh · $10.99
-
Other·J
TenPercentOwner
$1.6M
148.2K sh · $11.00
-
Other·U
Director
—
27 sh
-
Other·U
Chief Executive Officer
—
15.5K sh
-
Other·U
Director
—
133 sh
-
Other·U
Chief Medical Officer
—
360 sh
-
Other·U
Director
—
2.3K sh
-
Other·U
Kowieski Mark KEY
Chief Financial Officer
—
11.8K sh
-
Sell·S
TenPercentOwner
$42.6K
4.0K sh · $10.65
Own -3%
-
Sell·S
TenPercentOwner
$53.3K
5.0K sh · $10.66
Own -15%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Dec 17, 2025 | Brady Todd C | Other D | 1.2K | — |
| Dec 17, 2025 | Brady Todd C | Other D | 1.2K | — |
| Dec 17, 2025 | Brady Todd C | Other D | 5.8K | — |
| Dec 17, 2025 | WIDDER KENNETH J | Other D | 5.8K | — |
| Dec 17, 2025 | WIDDER KENNETH J | Other D | 1.2K | — |
| Dec 17, 2025 | WIDDER KENNETH J | Other D | 1.2K | — |
| Dec 17, 2025 | REED VICKIE S | Other D | 1.2K | — |
| Dec 17, 2025 | REED VICKIE S | Other D | 1.2K | — |
| Dec 17, 2025 | REED VICKIE S | Other D | 5.8K | — |
| Dec 17, 2025 | D'Onofrio Matthew J KEY | Other D | 70.0K | — |
| Dec 17, 2025 | D'Onofrio Matthew J KEY | Other D | 64.8K | — |
| Dec 17, 2025 | Hill Malcolm R | Other D | 1.2K | — |
| Dec 17, 2025 | Hill Malcolm R | Other D | 5.8K | — |
| Dec 17, 2025 | Hill Malcolm R | Other D | 1.2K | — |
| Dec 17, 2025 | Smeal Benjamin C. | Other D | 5.8K | — |
| Dec 17, 2025 | Smeal Benjamin C. | Other D | 1.1K | — |
| Dec 17, 2025 | PYSZCZYMUKA GREG | Other D | 1.2K | — |
| Dec 17, 2025 | PYSZCZYMUKA GREG | Other D | 5.8K | — |
| Dec 17, 2025 | CARLSON MARILYN R. | Other D | 11.0K | — |
| Dec 17, 2025 | CARLSON MARILYN R. | Other D | 17.3K | — |
| Dec 17, 2025 | GARNER CAM L | Other D | 8.8K | — |
| Dec 17, 2025 | GARNER CAM L | Other D | 1.3K | — |
| Dec 17, 2025 | GARNER CAM L | Other D | 1.5K | — |
| Dec 17, 2025 | Kowieski Mark KEY | Other D | 13.0K | — |
| Dec 17, 2025 | Kowieski Mark KEY | Other D | 17.3K | — |
| Dec 17, 2025 | Mack Daniel | Other J | 434.0K | $4.8M |
| Dec 17, 2025 | Mack Daniel | Other J | 117.0K | $551.2K |
| Dec 17, 2025 | Mack Daniel | Other J | 117.0K | $551.2K |
| Dec 17, 2025 | Mack Daniel | Other J | 158.5K | $1.7M |
| Dec 17, 2025 | Mack Daniel | Other J | 250.6K | $2.8M |
| Dec 17, 2025 | Mack Daniel | Other J | 148.2K | $1.6M |
| Dec 16, 2025 | Brady Todd C | Other U | 27 | — |
| Dec 16, 2025 | D'Onofrio Matthew J KEY | Other U | 15.5K | — |
| Dec 16, 2025 | Hill Malcolm R | Other U | 133 | — |
| Dec 16, 2025 | CARLSON MARILYN R. | Other U | 360 | — |
| Dec 16, 2025 | GARNER CAM L | Other U | 2.3K | — |
| Dec 16, 2025 | Kowieski Mark KEY | Other U | 11.8K | — |
| Nov 6, 2025 | Klein Roger M. | Sell S | 4.0K | $42.6K |
| Nov 6, 2025 | Klein Roger M. | Sell S | 5.0K | $53.3K |
About EVOK insider trading
This page tracks insider transactions for Evoke Pharma Inc (EVOK) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.